Merger Boosts Raptor Pipeline, Clears Path to Nasdaq Listing July 29, 2009 By Catherine Hollingsworth
Rigel Takes Hit on R788 Data, But Partnering Thesis Intact July 27, 2009 By Catherine Hollingsworth Rigel Pharmaceuticals Inc. said a midstage study of rheumatoid arthritis drug R788 missed the mark, a development that might complicate partnership talks but won't end them. (BioWorld Today)Read More
Celgene Pops on Strong Quarter, Positive Phase III Revlimid Trial July 24, 2009 By Catherine Hollingsworth
Limerick Raises $15M to Advance Transplant, Metabolic Programs July 16, 2009 By Catherine Hollingsworth
